Predictive Factors of Severe Adverse Events in Pediatric Oncologic Patients with Febrile Neutropenia

Volume 21, Issue 12, December 2020, Pages 3487-3492

Jutarat Thangthong; Suvaporn Anugulruengkitt; Supanun Lauhasurayotin; Kanhatai Chiengthong; Hansamon Poparn; Darintr Sosothikul; Piti Techavichit

• View Article
• PDF 423.04 K

A Randomized, Open-Labeled, Prospective Controlled Study to Assess the Efficacy of Frontline Empirical Intravenous Piperacillin/Tazobactam Monotherapy in Comparison with Ceftazidime Plus Amikacin for Febrile Neutropenia in Pediatric Oncology Patients

Volume 20, Issue 9, September 2019, Pages 2733-2737

Ruchirek Kamonrattana; Lalita Sathitsamitphong; Worawut Choeyprasert; Pimlak Charoenkwan; Rungrote Natesirinilkul; Kanda Fanhchaksai

• View Article
• PDF 281.26 K

Bacterial Spectrum and Antimicrobial Resistance Pattern in Cancer Patients with Febrile Neutropenia

Volume 20, Issue 5, May 2019, Pages 1471-1474

Hassan Ali Vahedian-Ardakani; Mansour Moghimi; Mohammad Shayestehpour; Masoud Doosti; Nakisa Amid

• View Article
• PDF 260.08 K

Risk Factors for Invasive Fungal Infection among Thai Oncologic Patients with Febrile Neutropenia and Cutaneous Presentation: A 5-Year Retrospective Study in Southern Thailand

Volume 18, Issue 12, December 2017, Pages 3239-3243

Kumpol Aiempanakit; Surarit Naorungroj; Kanokphorn Chiratikarnwong; Sauvarat Auepemkiate; Benjawan Apinantriyo

• View Article
• PDF 276.96 K

Pegfilgrastim Versus Filgrastim for Primary Prophylaxis of Febrile Neutropenia in Patients with non-Hodgkin’s Lymphoma: A Cost-Effectiveness Study

Volume 18, Issue 10, October 2017, Pages 2703-2707

Ramin Ravangard; Najme Bordbar; Khosro Keshavarz; Mehdi dehghani

• View Article
• PDF 336.02 K

Incidence, Risk Factors, and Outcomes of Febrile Neutropenia in Thai Hematologic Malignancy Patients Receiving Chemotherapy: A 6-year Retrospective Cohort Study

Volume 16, Issue 14, December 2015, Pages 5945-5950

• View Article
• PDF 510.52 K

Which One is More Effective, Filgrastim or Lenograstim, During Febrile Neutropenia Attack in Hospitalized Patients with Solid Tumors?

Volume 16, Issue 3, March 2015, Pages 1185-1189

• View Article
• PDF 348.51 K

Clinical Study on Safety and Efficacy of JiSaiXin (Recombinant Human Granulocyte Colony Stimulating Factor Injection Manufactured in China) for Chinese Undergoing Chemotherapy

Volume 16, Issue 1, January 2015, Pages 299-301

• View Article
• PDF 337.29 K

Leucogen Tablets at 60 mg Three Times per Day are Safe and Effective to Control Febrile Neutropenia

Volume 15, Issue 19, December 2014, Pages 8495-8497

• View Article
• PDF 344.92 K

Risk of Serious Neutropenic Events in Cancer Patients Treated with Bevacizumab: A Meta-analysis

Volume 14, Issue 4, April 2013, Pages 2453-2459

• View Article
• PDF 603.11 K

Outcome of Febrile Neutropenic Patients on Granulocyte Colony Stimulating Factor in a Tertiary Care Hospital

Volume 13, Issue 6, June 2012, Pages 2523-2526

• View Article
• PDF 366.92 K

Meropenem Monotherapy as an Empirical Treatment of Febrile Neutropenia in Childhood Cancer Patients

Volume 11, Issue 1, January 2010, Pages 123-126

• View Article
• PDF 32.39 K

Imipenem in the Treatment of Febrile Neutropenic Children

Volume 10, Issue 5, May 2009, Pages 921-923

• View Article
• PDF 26.32 K

Factors Influencing In-hospital Length of Stay and Mortality in Cancer Patients Suffering from Febrile Neutropenia

Volume 9, Issue 2, February 2008, Pages 303-308

• View Article
• PDF 40.16 K